News Center
Suzhou Kintor Won "Extraordinary Biopharmaceutical Enterprise Award" of China Financing in 2019
Suzhou Kintor Won "Extraordinary Biopharmaceutical Enterprise Award" of China Financing in 2019
(Summary description)[June 21, 2019, Hong Kong, China] The awarding ceremony of the "2019 China Financing Awards" sponsored by "China Financing", a high-end financial magazine on Hong Kong capital market, was successfully held in Hong Kong. Suzhou Kintor Pharmaceuticals, Inc. ("Suzhou Kintor"), together with nine pharmaceutical enterprises such as WuXi Biologics, Henlius, CanSinoBio, Innovent Biologics and Hua Medicine, won "Extraordinary Biopharmaceutical Enterprise Award" of China Financing in 2019. Dr. Youzhi Tong, Chairman and Chief Executive Officer of Suzhou Kintor , was invited to attend the ceremony and accept the award on behalf of the company.
- Categories:Company news
- Author:
- Origin:
- Time of issue:2019-06-21 15:23
- Views:

Suzhou Kintor has won this honor by virtue of its meticulous spirit demonstrated in unremitting commitment to the research and development of new anti-cancer drugs, and the research progress achieved, which has greatly enhanced the brand influence and reputation of Suzhou Kintor in Hong Kong capital market and affirmedthe development achievements in the field of innovative medicine of Suzhou Kintor.
Business
News Center
Contact Us
Find Us


Copyright: Kintor Pharmaceutical Limited retains all copyrights. 苏ICP备19028699号-2 Powered by 300.cn
Complaints and Suggestions Tel: +86 512 62639935 Email: public@kintor.com.cn